CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: In a CML mouse engraftment model, Cxcl12 deletion in MSCs and CAR cells led to increased LSC cycling and TKI sensitivity, suggesting that stromal-derived Cxcl12 drives quiescence and TKI resistance.